Pharmaceutical
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Advanced pharmaceutical formulation for targeted therapeutic intervention.